FPHAX Mutual Fund

NAV$32.66

AUM$703M

TER0.67%

Holdings60

FPHAX Mutual Fund

NAV$32.66

Fidelity Select Pharmaceuticals Portfolio

AUM$703M

TER0.67%

Holdings60

✓All holdings

✓Overlap Analysis

✓ETF Screener

✓Compare ETFs

$149$60/mo

Limited to first 500

Get Started →

Showing top 20 of 60 holdings— Unlock all holdings(as of Feb 28, 2026)

#	Ticker ↕	Name ↕	Weight ↓	Shares ↕	Mkt Value ↕	Share Chg	Sector	Industry
1	LLY	Eli Lilly & Co	25.18%	362,801	$381.66M	••••••	••••••••	••••••••
2	GSK	Glaxosmithkline Finance Plc	10.07%	2,581,360	$152.64M	••••••	••••••••	••••••••
3	JNJ	Johnson & Johnson	7.53%	459,700	$114.20M	••••••	••••••••	••••••••
4	UCB:BR	Ucb Sa	5.01%	254,500	$75.87M	••••••	••••••••	••••••••
5	AZN:LN	AstraZeneca PLC	4.93%	358,250	$74.68M	••••••	••••••••	••••••••
6	ROG:SM	Rogers Corp	4.93%	157,090	$74.76M	••••••	••••••••	••••••••
7	GILD	Gilead Sciences Inc	4.64%	472,500	$70.38M	••••••	••••••••	••••••••
8	MRK	Merck & Company Inc	4.59%	561,536	$69.53M	••••••	••••••••	••••••••
9	ELAN	Elanco Animal Health, Inc Cvr	4.42%	2,536,200	$66.96M	••••••	••••••••	••••••••
10	NMF	Fidelity Securities Lending Cash Central Fund	4.26%	64,528,910	$64.54M	••••••	••••••••	••••••••
11	LEGN	LEGEND BIOTECH CORP-ADR	3.26%	2,598,400	$49.37M	••••••	••••••••	••••••••
12	JAZZ:IE	Jazz Pharmaceuticals Plc	2.85%	227,700	$43.27M	••••••	••••••••	••••••••
13	MRNA	Moderna therapeutics	2.43%	688,800	$36.90M	••••••	••••••••	••••••••
14	RPRX	Royalty Pharma Plc Cl A	2.29%	750,500	$34.68M	••••••	••••••••	••••••••
15	VTRS	Viatris Inc.	1.70%	1,729,600	$25.82M	••••••	••••••••	••••••••
16	TUB:BR	Financiere De Tubize Sa	1.62%	91,587	$24.51M	••••••	••••••••	••••••••
17	BNTX:FF	Biontech Se Adr	0.96%	132,653	$14.62M	••••••	••••••••	••••••••
18	MRCG:FF	Merck Kgaa	0.95%	94,700	$14.35M	••••••	••••••••	••••••••
19	BIIB	Biogen Inc 3.625 9/22	0.92%	73,000	$14.00M	••••••	••••••••	••••••••
20	OCUL	Ocular Therapeutix Inc	0.79%	1,331,717	$11.91M	••••••	••••••••	••••••••

40+ more holdings available

See all 60 holdings with sector, industry, share changes & CSV export

Unlock All Holdings — $149 $60/mo

Limited to first 500 subscribers - Cancel anytime

FPHAX Mutual Fund All Holdings

FPHAX holdings total 60 positions. The top 10 holdings account for 75.6% of the fund, led by Eli Lilly & Co at 25.2%, Glaxosmithkline Finance Plc at 10.1%, Johnson & Johnson at 7.5%.

FPHAX portfolio concentration is relatively high, with the top 10 representing 75.6% of total assets. The largest sector exposure is Health Care at 80.1%.

FPHAX sector allocation provides a detailed breakdown. FPHAX overlap tool shows how holdings compare to other funds in your portfolio.